[Impact of pretreatment with P2Y12 inhibitors in patients with acute coronary syndromes without ST elevation. Analysis of 2 multicenter registries].

Alan R Sigal Mirza Rivero Mayra MezaGerardo FilippaGastón Procopio Camila M Abud Sebastián NaniMartín OdoneErnesto Duronto Juan Pablo Costabel

Published in: Archivos peruanos de cardiologia y cirugia cardiovascular (2023)

Pretreatment was used in almost half of the patients, mainly with clopidogrel, and did not show a reduction in ischemic events in patients with NSTACS.

Keyphrases

acute coronary syndrome
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
percutaneous coronary intervention
antiplatelet therapy
peritoneal dialysis
prognostic factors
clinical trial
ischemia reperfusion injury
coronary artery disease
cerebral ischemia